Ask AI

Expert Guidance and Clinical Resources to Guide Treatment Decisions and AE Management in Mantle Cell Lymphoma

Enhance your ability to identify which patients with mantle cell lymphoma (MCL) are most likely to benefit from chemotherapy-free treatment options based on expert guidance and clinical evidence from emerging therapies to optimize outcomes through interactive decision support tools for MCL and managing BTK inhibitor-related adverse events, a ClinicalThought commentary, and certified text module with accompanying downloadable slides.  

Share

Program Content

Activities

MCL US IDST
Interactive Treatment Decision Tool for MCL: A US Perspective
Tool
Congratulations: You achieved a completion on 04/09/2022

Released: February 25, 2026

Tool for BTKi AEs in MCL
Interactive Tool to Guide the Management of BTK Inhibitor–Related Adverse Events in MCL
Tool
Congratulations: You achieved a completion on 04/09/2022

Released: April 27, 2026

Activities

Treatment Recommendations for MCL
Treatment Decision Support for Evolving MCL Treatment Paradigms
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 26, 2026

Activities

Expert Guidance for Mantle Cell Lymphoma
Expert Guidance and Clinical Resources to Improve the Care of Patients With Mantle Cell Lymphoma
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: May 19, 2026

Expires: November 18, 2026

Activities

Expert Guidance for Mantle Cell Lymphoma Slides
Expert Guidance and Clinical Resources to Improve the Care of Patients With Mantle Cell Lymphoma
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 19, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca